|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Arterial oxygen tension (PaO2) is known to decrease with age, and this is accompanied by a number
of changes in mechanical properties of the lungs, including loss of elastic recoil and increase in closing volume. The changes in respiratory mechanics with age could induce greater ventilation/perfusion (
A/
) mismatch and thus explain the decrease in Pa O2. In 64 normal subjects aged 18 to 71 yr
(lifetime nonsmokers with normal spirometry), we measured
A/
inequality and arterial respiratory
blood gases (Pa O2 and PaCO2) at rest in the seated position.
A/
mismatch, represented by the second moments of the blood flow and ventilation distributions (log SDQ and log SDV) increased with
age, but only slightly (mean log SDQ was 0.36 at age 20 yr and 0.47 at age 70 yr). Pa O2 fell by a correspondingly small amount of 6 mm Hg. Previously established upper 95% confidence limits for log
SDQ (0.60) and log SDV (0.65) in subjects at age 20 yr were confirmed. At age 70 yr, the upper limits
of reference for log SDQ are 0.70 and for log SDV 0.75. The study shows that an increased alveolar-
arterial O2 gradient with age is due to
A/
inequality rather than to shunting.
| |
INTRODUCTION |
|---|
|
|
|---|
The effect of aging on the normal lung has received considerable attention over the years. Elastic recoil is progressively reduced (1), VC and maximal expiratory flow rates fall (2), closing volume is increased (3), and PaO2 diminishes (4). Since PaCO2 does not rise, the decrease in PaO2 must indicate an increase in the alveolar-arterial PO2 difference (AaPO2).
The AaPO2 will increase if any one or more of three forms
of gas-exchange defect develop: (1) right-to-left shunting of
venous blood; (2) diffusion limitation of alveolar-capillary O2
exchange; or (3) ventilation-perfusion (
A/
) inequality.
Right-to-left shunting can occur within the lungs (or through
defects in the atrial septum), and this form of defect can be
conveniently termed intrapulmonary shunting. In addition,
PaO2 can be reduced by so-called postpulmonary shunting, in
which bronchial or thebesian venous blood enters the oxygenated blood downstream of the lungs. In the first case, mixed
venous blood never sees alveolar gas; in the second case, normally oxygenated blood passes into the bronchial and myocardial vasculature before it reaches the systemic arterial vessels
as deoxygenated blood.
Each of these varied causes of an increased AaPO2 could occur in normal subjects. Very few studies have been performed
with methods that can distinguish among them, and those few
have focused mainly on young, active normal volunteers.
Those studies incorporating older subjects have suggested that
A/
inequality may increase significantly with age (5). Intrapulmonary shunts have been found to be either small (mainly
less than 1% of the cardiac output) or nonexistent (5), postpulmonary shunts appear to be negligible (5), and no evidence for diffusion limitation has been found during rest (5-
8). For older subjects, these conclusions are, however, tentative, having been based on very small numbers of subjects (9).
Since the known changes in lung mechanical properties
with age referred to earlier could cause
A/
inequality to increase, the present study was designed to determine whether
there was indeed an increase in
A/
mismatching with age,
and if so whether this accounts for any accompanying decline
in PaO2. The principal tool used to answer these questions was
the multiple inert-gas elimination technique (MIGET).
| |
METHODS |
|---|
|
|
|---|
Selection of Subjects
Sixty four normal subjects were studied. All were residents of Barcelona, Spain, and were lifetime nonsmokers not employed in jobs exposing them to known pulmonary toxins. The subject's ages ranged from 18 to 71 yr; there were 21 females and 43 males. None had any history of respiratory, cardiovascular, or systemic disease other than occasional upper-respiratory infections. No such episode had occurred within 2 mo prior to study. Physical examination was within normal limits, and pulmonary function tests (Model 1070; Med-Graphics, St. Paul, MN) revealed normal forced spirometry (Table 1). No FEV1 values were less than 80% predicted. Mean FEV1 was 105 ± 11% predicted. The decrease in the ratio of FEV1 to FVC with age was 0.2 per year, which was within the expected range for healthy subjects.
|
Subject Preparation
We performed clinical evaluations and pulmonary function testing after giving the subjects an explanation of all procedures and receiving
their informed consent. Within a week, each subject then returned after an overnight fast for the principal study of gas exchange. After adequate ulnar collateral arterial bloodflow was assured, a 20-gauge cannula was placed in the radial artery of the nondominant hand. A
catheter was placed into a vein on the contralateral arm. In both cases,
sterile technique and local anesthesia (1% lidocaine) were used. Not
less than 30 min after the beginning of an intravenous infusion of a
sterile mixture of dissolved inert gases (for the MIGET; see the subsequent discussion), the subject was connected through a nonrebreathing valve to a heated 10 L volume metallic mixing box (10). Ventilation was continuously recorded with a calibrated Wright respirometer,
and mixed expired O2 and CO2 concentrations were continuously
measured with a calibrated respiratory mass spectrometer (SensorLab
N/S V12866; Fisons, Cheshire, UK). These measurements provided a
continuous record of O2 uptake and CO2 elimination. These data were
also used to confirm a steady state of gas exchange both by constancy of values to within ± 5% and by values of the respiratory exchange ratio lying with physiologic limits, an important requirement for interpretation of any gas-exchange data.
O2 was used to estimate cardiac
output according to the Fick principle and an assumed arteriovenous
O2 difference of 50 ml · dl
1. This was necessary for the seven subjects
(of the total of 64) in whom direct cardiac output measurements required for applying the MIGET were unavailable; correlations of
measured and computed cardiac output values for the 57 other subjects provided validation for the computed values as a reasonable substitute in these seven.
Cardiac Output Measurements
The indocyanine green dye technique was used to measure cardiac
output. To inscribe the dye curve, 5 mg of dye in 1 ml of water was
rapidly flushed into the venous catheter and arterial blood was withdrawn at a constant rate of 20 ml · min
1. In these resting subjects, adequate curves were obtained prior to recirculation for the conventional
Stewart-Hamilton analysis with a cardiac output computer (DC-410;
Waters Instruments Inc., Rochester, MN). Duplicate measurements
requiring about 40 ml blood in all were made and the results averaged.
The MIGET
Using methods described previously from this laboratory (11), we
used the MIGET to assess
A/
relationships in subjects at rest in
the seated upright position. To measure
A/
inequality, we used
previously described indices (10), principally the second moment of
the distributions of ventilation and blood flow on a logarithmic scale
log SDV and log SDQ, respectively. The analysis separately yields a
value for the intrapulmonary shunt as the fraction of the cardiac output perfusing regions with a
A/
ratio below 0.005, the lower limit of
resolution of the method (12, 13). The total perfusion to areas with
subnormal ventilation (low
A/
areas) was defined as the percent
perfusion to lung units with a
A/
ratio above 0.005 and below 0.1. Duplicate or triplicate measurements were attempted in order to compute the intrasubject variance of the outcome variables with a previously described approach involving the pooling of normalized data
from many subjects (9). Such sequential samples were taken 5 min apart, with the inert gas infusion continuing, and including catheter dead space, each sample required 10 ml of blood. In all, 159 samples were successfully taken and processed from the 64 subjects.
Arterial Blood-gas Measurements
Immediately after each inert gas sample was collected as described above, a 3-ml arterial blood sample was taken into a heparinized syringe. Bubbles were removed and the sample was iced prior to measurements, which were made within 30 min. P O2, PCO2, pH, O2 saturation, and [Hb] were measured directly from each sample (BG3 and IL482; Instrumentation Laboratories, Milan, Italy). Values were corrected to body temperature measured once prior to connecting the subject to the mouthpiece of the spirometer.
Statistical Analysis
Results given in the text are expressed as mean ± SD. Linear regression was used to analyze relationships between principal variables.
Measured and calculated values of cardiac output were compared
with Student's paired t test. Both PaO2 expected from the measured
amount of intrapulmonary shunting and
A/
inequality were calculated (12) and compared with the measured Pa O2 value for each subject with Student's paired t test.
| |
RESULTS |
|---|
|
|
|---|
A/
Inequality
Figure 1 shows the principal dispersion data for the
A/
distribution (log SDQ and log SDV). The two variables explicitly exclude contributions of intrapulmonary shunting, which were
generally very small and which are analyzed later. Very few
data lay above the previously reported reference limits for
young normal subjects (9). Thus, in only two cases was log
SDQ above the reference limit of 0.6, and in only six cases was
log SDV above its limit of 0.65. Nevertheless, an in-depth
analysis of extreme data points did not yield any insight into
the mechanisms that were involved.
|
The dispersion of
A/
distributions increases with age.
The rates of increase are similar for both log SDQ and log
SDV, but it must be emphasized that the magnitude of the age
effect is on average physiologically small and clinically not significant. For example, from the log SDQ regression line, mean
values would be only 0.36 at age 20 yr and 0.47 at age 70 yr. As
shown by West (14), these values of dispersion correspond to
an AaPO2 of only about 5 mm Hg and 15 mm Hg, respectively,
or to arterial PO2 values of about 95 to 100 mm Hg and 85 to
90 mm Hg, respectively, depending on the arterial PCO2. Consequences for arterial O2 saturation would be very small. In
contrast, patients with severe lung disease often develop log
SDQ values of 2.0 or greater (15); a perfectly homogeneous
lung would have a log SDQ of 0.
The variance in both log SDQ and log SDV is considerable, as Figure 1 shows. The sources of this variance are discussed subsequently, but the low correlation coefficients of 0.35 and 0.24 for each variable indicate that only 12% of the total variance is age-related.
The impact of intrasubject variance due to a combination
of experimental errors and biologic change in samples taken
5 min apart was examined by normalizing and then pooling
the dispersion parameters for each subject (9). In the present
study, this approach indicated that only 11% of the total variance of the dispersion indices (Figure 1) was due to intrasubject variation. The majority of the variance in
A/
dispersion therefore remained unexplained, but must have been
of intersubject origin. An obvious candidate for the cause of
such intersubject variance is the range of spirometric values (Table 1). However, when log SDQ values were plotted against either FEV1 as %predicted or against the FEV1/FVC ratio, no
evidence was found that these spirometric variables had any
relationship to
A/
inequality. We were therefore unable to
account for the majority of the observed variance in
A/
inequality through any physiologic variable or possible measured source of variability such as age, height, weight, expiratory flow rates, or experimental errors.
Since log SDQ and log SDV do not reflect unventilated regions (nor intrapulmonary shunting), we examined the amount
of blood flow perfusing areas with a subnormal
A/
ratio
(i.e., areas of
A/
< 0.1). It is these areas that contribute most
to the size of the AaPO2 and which would therefore cause a decrease in arterial PO2. Expressed as a percentage of the cardiac
output, this low
A/
area perfusion is shown in Figure 2. In
all but seven of the 64 subjects, there was no more than 0.75%
of the cardiac output in such areas, a trivial amount in terms of
arterial oxygenation. No subject had more than 3% of the cardiac output in low
A/
regions.
|
Arterial Blood-gas Data
Pa O2 fell with age as expected, but only slightly (Figure 3). Because of variance, the slope of the regression line was only just significantly negative (p = 0.05, one-tailed test), and indicated a mean decrease of about 6 mm Hg, from 102.3 mm Hg at age 20 yr to 96.5 mm Hg at age 70 yr. However, and unexpectedly, arterial PCO2 also fell with age, by almost 4 mm Hg, from a mean of 38.0 mm Hg to 34.3 mm Hg over the same age range (p = 0.02). When the alveolar gas equation was used to calculate a PaO2 that would have existed had the arterial PCO2 been 40 mm Hg in every subject, rather than tending to fall with age, a more clear-cut effect of age became apparent (Figure 3, lower left panel ). When this was done, the mean corrected arterial PO2 fell by 10 mm Hg, from 100 mm Hg at age 20 yr to 90 mm Hg by age 70 yr. It is not apparent why older subjects hyperventilated, but it is evident that this should be considered in interpreting age-dependent changes in PaO2. Owing to the very large relative variance, the apparently positive slope of AaPO2 with age (Figure 3, lower right panel ) was not significant. The variance of AaPO2 is expected to be relatively large, since AaPO2 is the generally small difference between two large numbers, alveolar and arterial PO2. This consequence of normal error propagation also explains the negative values of AaPO2, which are to be expected on occasion in the normal population. However, despite the large variance in PO2 and in AaPO2, the inert-gas data and those for O2 are internally consistent with each other.
|
Additionally, the mean value of PaO2 for all 64 subjects
(100 ± 8 mm Hg) was not significantly different from the PaO2
predicted from the measured combination of shunting plus
perfusion of low
A/
areas as recovered from the inert-gas
data (98 ± 11.6 mm Hg). Had there been significant alveolar-
capillary diffusion limitation of O2, and/or bronchial venous or
thebesian (postpulmonary) shunts reducing PaO2, the measured PaO2 would have been systematically lower than the
value predicted by the inert gas data. That this was not the
case argues against the presence of such phenomena to any
measurable degree.
| |
DISCUSSION |
|---|
|
|
|---|
A/
Inequality, O2 Exchange, and Age: Main Findings
The principal findings of this study are: (1) that
A/
inequality, but not intrapulmonary shunting, does indeed increase with age as previously expected; ( 2) that based on our group of 64 subjects aged from 18 to 71 yr, the increase over the span of about 50 yr is physiologically very small; (3) that most of the variance in
A/
mismatch over the age range of the group is not due to aging, and remains unexplained; and (4) that the decrease PaO2 with age is also quite small but is internally
consistent with the
A/
changes measured independently.
A/
inequality was characterized in most subjects by a
narrow distribution that widened slightly with age, together
with a very small shunt of less than 1% of the cardiac output in
90% of cases. Both log SDQ and log SDV increased by about
0.1 between the ages of 20 yr and 70 yr. Thus, log SDQ increased from 0.36 to 0.47, which is consistent with a decrease
in Pa O2 of only about 6 mm Hg. The cause(s) of the increase in
A/
mismatch with age were examined as far as possible
from the data collected. Only about 10% of the total variance
in dispersion was attributable to age. A similar amount was
due to intrasubject variability, but none was due to variation
in FEV 1 % predicted, the FEV1/FVC ratio, weight, or height.
It is certainly possible that age could increase
A/
inequality
as a result of increases in closing volume (3), such that in older
subjects some airways are closed during normal tidal breathing, reducing local ventilation and hence producing
A/
mismatching. We did not measure closing volume, but since this
mechanism is highly unlikely to compromise
A/
relationships in young normal subjects, we would argue that closing
volume is not a strong candidate for causing the variance in
A/
matching. In a very much smaller number of subjects
consisting of both young and middle-aged volunteers studied for other reasons, differences in closing volume were apparent as a function of age, but there were no evident effects on
A/
mismatching of increasing closing volume by water immersion
to the neck (16). When both dry and immersed, the older subjects had greater
A/
mismatching than the younger subjects. Taken together, these findings also do not support a role
for airway closure as an explanation for age-related
A/
inequality.
Even though no cause for the effects of age were identified,
approximate upper limits to
A/
inequality could be defined across the 50-yr span from age 20 yr to 70 yr. Figure 1 shows that the 95% upper confidence limits found previously for
young (20 to 40 yr old) normal subjects (9) can be retained.
For log SDQ, this limit is 0.60, and for log SDV it is 0.65. With the 0.1 increase in both parameters by age 70 yr, a reasonable estimate of the 95% upper confidence limit at age 70 yr would be 0.1 units greater for each parameter, at 0.70 for log SDQ
and 0.75 for log SDV. These estimates are compatible with the
95% confidence interval (CI) calculated from individual data in
Figure 1, although greater precision would require a greater
number of subjects, an undertaking that is probably not justified.
The establishment of such upper confidence limits is of clinical utility. Most studies of patients with lung disease are done with older subjects because most of the diseases of interest are more common as age increases.
It was something of a surprise that both PaO2 and
A/
inequality changed so little with age, especially in light of prior work showing larger decreases in P O2 with age (17). However, more recent data (18) are more in line with our findings.
Whether the differences between earlier and more recent work
reflect methodologic differences or differences in subject selection cannot be answered.
In summary, this study of 64 normal subjects aged 18 to 71 yr has confirmed earlier suspicions that
A/
inequality increases with age. The effects of age are, however, very small,
with dispersion (i.e., log SDQ) increasing on average by only
about 0.1, from 0.36 at age 20 yr to 0.47 at age 70 yr. The data
fit well with concurrently measured indices of arterial oxygenation, which showed a small decline of only about 6 mm Hg
over this age range. There was far more variance in
A/
inequality among the subjects than could be explained by age, and
candidates for sources of this variance such as experimental
errors and differences in spirometric indices, body weight, and
height were excluded. The explanation remains to be found.
Although previously established 95% upper confidence limits
for the
A/
dispersion parameters log SDQ and log SDV in
young subjects continue to fit the younger subjects in the
present group, the increase in
A/
mismatching with age sugg ests that these limits of normality be raised for older subjects.
Thus, at age 20 yr, the upper limit of reference for log SDQ is
0.60, whereas at age 70 yr it would be 0.70. The upper limits
for log SDV are 0.65 at 20 yr and, if raised, 0.75 at 70 yr, and
for subjects of intermediate age, linear interpolation between
these values is reasonable. These limits should be useful from
now on for interpreting
A/
dispersion data in older subjects with cardiopulmonary diseases.
| |
Footnotes |
|---|
Supported by Grants FIS 91/00160602E and FIS 95-0975 from the Fondo de Investigaciones Sanitarias, Grant SGR 95-0446 from the Comissionat per Universitats i Recerca de la Generalitat de Catalunya, ALFA-ETIR [2.042 (8)], and Grant HL-17731 from the National Heart, Lung and Blood Institute.
Dr. Wagner was a Visiting Professor in the PVI Programme at the Universitat de Barcelona during 1995 and 1996.
Correspondence and requests for reprints should be addressed to Josep Roca, M.D., Servei de Pneumologia, Hospital Clinic, Villarroel 170, Barcelona 08036, Spain.
(Received in original form June 4, 1996 and in revised form January 15, 1997).
Acknowledgments: The authors are grateful to Conxi Gistau, Teresa Lecha, Maite Simó, and Carmen Argaña of the Lung Function Laboratory of the Hospital Clínic for their outstanding technical support.
| |
References |
|---|
|
|
|---|
1.
Colebatch, H. J. H.,
I. A. Greaves, and
C. K. Y. Ng.
1979.
Exponential
analysis of elastic recoil and aging in healthy males and females.
J. Appl. Physiol.
47:
683-691
2.
Knudson, R. J.,
D. F. Clark,
T. C. Kennedy, and
D. E. Knudson.
1977.
Effect of aging alone on mechanical properties of the normal adult human lung.
J. Appl. Physiol.
43:
1054-1062
3. Buist, A. S., H. Ghezzo, N. R. Anthonisen, R. M. Cherniack, S. Ducic, P. T. Macklem, J. Manlieda, R. R. Martin, D. McCarthy, and B. B. Ross. 1979. Relationship between the single-breath N2 test and age, sex and smoking habit in three North American cities. Am. Rev. Respir. Dis. 120: 305-318 [Medline].
4. Sorbini, C. A., V. Grassi, E. Solinas, and G. Muiesan. 1968. Arterial oxygen tension in relation to age in healthy subjects. Respiration 25: 3-13 [Medline].
5. Wagner, P. D., R. B. Laravuso, R. R. Uhl, and J. B. West. 1974. Continuous distributions of ventilation-perfusion ratios in normal subjects breathing air and 100% O2. J. Clin. Invest. 54: 54-68 .
6.
Gale, G. E.,
J. Torre-Bueno,
R. E. Moon,
H. A. Salzman, and
P. D. Wagner.
1985.
Ventilation-perfusion inequality in normal humans during
exercise.
J. Appl. Physiol.
58:
978-988
7.
Torre-Bueno, J.,
P. D. Wagner,
H. A. Saltzman,
G. E. Gale, and
R. E. Moon.
1985.
Diffusion limitation in normal humans during exercise at
sea level and simulated altitude.
J. Appl. Physiol.
58:
989-995
8.
Wagner, P. D.,
G. E. Gale,
R. E. Moon,
J. E. Torre-Bueno,
B. W. Stolp, and
H. A. Saltzman.
1986.
Pulmonary gas exchange in humans exercising at sea level and simulated altitude.
J. Appl. Physiol.
61:
260-270
9.
Wagner, P. D.,
G. Hedenstierna,
G. Bylin, and
L. Lagerstrand.
1987.
Reproducibility of the multiple inert gas elimination technique.
J. Appl.
Physiol.
62:
1740-1746
10. Roca, J., and P. D. Wagner. 1993. Contribution of multiple inert gas elimination technique to pulmonary medicine. 1: principles and information content of the multiple inert gas elimination technique. Thorax 49: 815-824 [Abstract].
11. Rodriguez-Roisin, R., J. Roca, R. Guitart, A. G. Agusti, A. Torres, and P. D. Wagner. 1986. Measurements of distributions of ventilation-perfusion ratios: multiple inert gases elimination technique. Rev. Esp. Fisiol. 42: 465-482 [Medline].
12.
Evans, J. W., and
P. D. Wagner.
1977.
Limits on
A/
distributions
from analysis of experimental inert gas elimination.
J. Appl. Physiol.
36:
600-605
.
13. Dantzker, D. R., L. Brook, P. DeHart, J. Lynch, and J. Weg. 1979. Ventilation-perfusion distribution in the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 120: 1039-1052 [Medline].
14. West, J. B.. 1969. Ventilation-perfusion inequality and overall gas exchange in computer models of the lung. Respir. Physiol. 7: 88-110 [Medline].
15.
Wagner, P. D.,
J. R. Sutton,
J. T. Reeves,
A. Cymerman,
B. M. Groves, and
M. K. Malconian.
1987.
Operation Everest. II: pulmonary gas exchange during a simulated ascent of Mt. Everest.
J. Appl. Physiol.
63:
2348-2359
16.
Derion, T.,
H. J. Guy,
K. Tsukimoto,
W. Schaffartzik,
R. Prediletto,
D. C. Poole,
D. R. Knight, and
P. D. Wagner.
1992.
Ventilation-perfusion relationships in the lung during head-out water immersion.
J. Appl. Physiol.
72:
64-72
17.
Raine, J. M., and
J. M. Bishop.
1963.
A-a difference in O2 tension and
physiological dead space in normal man.
J. Appl. Physiol.
18:
284-288
18. Declaux, B., B. Orcel, B. Housset, W. A. Whitelaw, and J.-P. Derenne. 1994. Arterial blood gases in elderly persons with chronic obstructive pulmonary disease (COPD). Eur. Respir. J. 7: 856-861 [Abstract].
19. Cerveri, I., M. C. Zoia, F. Fanfulla, L. Spagnolatti, L. Berrayah, M. Grassi, and C. Tinelli. 1995. Reference values of arterial oxygen tension in the middle-aged and elderly. Am. J. Respir. Crit. Care Med. 152: 934-941 [Abstract].
20. Guénard, H., and R. Marthan. 1996. Pulmonary gas exchange in elderly subjects. Eur. Respir. J. 9: 2573-2577 [Abstract].
This article has been cited by other articles:
![]() |
H. A. Manrique, F. P. Gomez, P. A. Munoz, A. M. Pena, J. A. Barbera, J. Roca, and R. Rodriguez-Roisin Adenosine 5'-monophosphate in asthma: gas exchange and sputum cellular responses Eur. Respir. J., June 1, 2008; 31(6): 1205 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Polverino, F. P. Gomez, H. Manrique, N. Soler, J. Roca, J. A. Barbera, and R. Rodriguez-Roisin Gas Exchange Response to Short-Acting beta2-Agonists in Chronic Obstructive Pulmonary Disease Severe Exacerbations Am. J. Respir. Crit. Care Med., August 15, 2007; 176(4): 350 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Levin, R. B. Buxton, J. P. Spiess, T. Arai, J. Balouch, and S. R. Hopkins Effects of age on pulmonary perfusion heterogeneity measured by magnetic resonance imaging J Appl Physiol, May 1, 2007; 102(5): 2064 - 2070. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Casas, F. P. Gomez, B. Dahlen, J. Roca, J. A. Barbera, S-E. Dahlen, and R. Rodriguez-Roisin Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor Eur. Respir. J., September 1, 2005; 26(3): 442 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rodriguez-Roisin, M.J. Krowka, Ph. Herve, M.B. Fallon, and on behalf of the ERS Task Force Pulmonary-Hepatic Pulmonary-Hepatic vascular Disorders (PHD) Eur. Respir. J., November 1, 2004; 24(5): 861 - 880. [Full Text] [PDF] |
||||
![]() |
H. J. Mummery, B. W. Stolp, G. deL. Dear, P. O. Doar, M. J. Natoli, A. E. Boso, J. D. Archibald, G. W. Hobbs, H. E. El-Moalem, and R. E. Moon Effects of age and exercise on physiological dead space during simulated dives at 2.8 ATA J Appl Physiol, February 1, 2003; 94(2): 507 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. MANCINI, E. ZAVALA, J. MANCEBO, C. FERNANDEZ, J. A. BARBERA, A. ROSSI, J. ROCA, and R. RODRIGUEZ-ROISIN Mechanisms of Pulmonary Gas Exchange Improvement during a Protective Ventilatory Strategy in Acute Respiratory Distress Syndrome Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1448 - 1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. ECHAZARRETA, B. DAHLEN, G. GARCIA, C. AGUSTI, J. A. BARBERA, J. ROCA, S.-E. DAHLEN, and R. RODRIGUEZ-ROISIN Pulmonary Gas Exchange and Sputum Cellular Responses to Inhaled Leukotriene D4 in Asthma Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 202 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.L. Echazarreta, F.P. Gomez, J. Ribas, E. Sala, J.A. Barbera, J. Roca, and R. Rodriguez-Roisin Pulmonary gas exchange responses to histamine and methacholine challenges in mild asthma Eur. Respir. J., April 1, 2001; 17(4): 609 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. PEREZ-GUZMAN, A. TORRES-CRUZ, H. VILLARREAL-VELARDE, and M. H. VARGAS Progressive Age-related Changes in Pulmonary Tuberculosis Images and the Effect of Diabetes Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1738 - 1740. [Abstract] [Full Text] |
||||
![]() |
C. SANTOS, M. FERRER, J. ROCA, A. TORRES, C. HERNÁNDEZ, and R. RODRIGUEZ-ROISIN Pulmonary Gas Exchange Response to Oxygen Breathing in Acute Lung Injury Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 26 - 31. [Abstract] [Full Text] |
||||
![]() |
R. O. CRAPO, R. L. JENSEN, M. HEGEWALD, and D. P. TASHKIN Arterial Blood Gas Reference Values for Sea Level and an Altitude of 1,400 Meters Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1525 - 1531. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |